Live Breaking News & Updates on News Ratings For Fusion Pharmaceuticals Daily

Stay updated with breaking news from News ratings for fusion pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Leerink-partnrs , Raymond-james , Nasdaq , Perceptive-advisors , Hermes-inc , Fusion-pharmaceuticals-price-performance , Fusion-pharmaceuticals , Sphera-funds-management , Analyst-recommendations-for-fusion-pharmaceuticals , Fusion-pharmaceuticals-inc

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By William Blair

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […] ....

Canada , United-states , Raymond-james , William-blair , Forefront-analytics , Eagle-health-investments , News-ratings-for-fusion-pharmaceuticals-daily , Hedge-funds-weigh-in-on-fusion-pharmaceuticals , Fusion-pharmaceuticals-stock , Fusion-pharmaceuticals , Fusion-pharmaceuticals-inc , Yarbrough-capital

Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 12-Month High at $21.32

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares traded. The stock had previously closed at $21.24. Analysts Set New Price Targets Several brokerages have issued reports on […] ....

Canada , United-states , Fusion-pharmaceuticals-inc , News-ratings-for-fusion-pharmaceuticals-daily , Institutional-trading-of-fusion-pharmaceuticals , Fusion-pharmaceuticals-stock , Fusion-pharmaceuticals-company-profile , Renaissance-technologies , Royal-bank , Nasdaq , Tower-research-capital

Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 1-Year High at $21.32

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […] ....

Canada , United-states , Leerink-partnrs , Raymond-james , Fusion-pharmaceuticals-stock-performance , Nasdaq , Royal-bank , Fusion-pharmaceuticals , Perceptive-advisors , Fusion-pharmaceuticals-inc , Hermes-inc , Institutional-trading-of-fusion-pharmaceuticals

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By Wedbush

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Investment analysts at Wedbush decreased their Q1 2024 EPS estimates for Fusion Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.34) per share for the quarter, down from their prior estimate of […] ....

New-york , United-states , Canada , Leerink-partnrs , William-blair , Royal-bank , Tower-research-capital , York-state-common-retirement-fund , Nasdaq , Fusion-pharmaceuticals-inc , Geode-capital-management , Fusion-pharmaceuticals